pRetrosuper Myc shRNA Citations (11)

Originally described in: The ubiquitin-specific protease USP28 is required for MYC stability.
Popov N, Wanzel M, Madiredjo M, Zhang D, Beijersbergen R, Bernards R, Moll R, Elledge SJ, Eilers M Nat Cell Biol. 2007 Jul . 9(7):765-74. PubMed Journal

---

Articles Citing pRetrosuper Myc shRNA

Articles
Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells. Lu JJ, Meng LH, Shankavaram UT, Zhu CH, Tong LJ, Chen G, Lin LP, Weinstein JN, Ding J. Biochem Pharmacol. 2010 Jul 1;80(1):22-30. doi: 10.1016/j.bcp.2010.02.016. Epub 2010 Mar 3. PubMed
Downregulation of c-MYC protein levels contributes to cancer cell survival under dual deficiency of oxygen and glucose. Okuyama H, Endo H, Akashika T, Kato K, Inoue M. Cancer Res. 2010 Dec 15;70(24):10213-23. doi: 10.1158/0008-5472.CAN-10-2720. Epub 2010 Oct 27. PubMed
Selective glucocorticoid receptor translational isoforms reveal glucocorticoid-induced apoptotic transcriptomes. Wu I, Shin SC, Cao Y, Bender IK, Jafari N, Feng G, Lin S, Cidlowski JA, Schleimer RP, Lu NZ. Cell Death Dis. 2013 Jan 10;4:e453. doi: 10.1038/cddis.2012.193. PubMed
Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells. Sharma BK, Kolhe R, Black SM, Keller JR, Mivechi NF, Satyanarayana A. FASEB J. 2016 Jan;30(1):262-75. doi: 10.1096/fj.15-277749. Epub 2015 Sep 1. PubMed
c-MYC Drives Breast Cancer Metastasis to the Brain, but Promotes Synthetic Lethality with TRAIL. Lee HY, Cha J, Kim SK, Park JH, Song KH, Kim P, Kim MY. Mol Cancer Res. 2019 Feb;17(2):544-554. doi: 10.1158/1541-7786.MCR-18-0630. Epub 2018 Sep 28. PubMed
Transcriptional upregulation of c-MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma. Hong J, Maacha S, Belkhiri A. Mol Oncol. 2018 Dec;12(12):2191-2208. doi: 10.1002/1878-0261.12395. Epub 2018 Nov 5. PubMed
Establishment and characterization of a novel vincristine-resistant diffuse large B-cell lymphoma cell line containing the 8q24 homogeneously staining region. Mizuno S, Hanamura I, Ota A, Karnan S, Kanasugi J, Nakamura A, Takasugi S, Uchino K, Horio T, Goto M, Murakami S, Gotou M, Yamamoto H, Watarai M, Shikami M, Hosokawa Y, Miwa H, Taniwaki M, Ueda R, Nitta M, Takami A. FEBS Open Bio. 2018 Nov 20;8(12):1977-1991. doi: 10.1002/2211-5463.12538. eCollection 2018 Dec. PubMed
The deubiquitinase USP36 Regulates DNA replication stress and confers therapeutic resistance through PrimPol stabilization. Yan Y, Xu Z, Huang J, Guo G, Gao M, Kim W, Zeng X, Kloeber JA, Zhu Q, Zhao F, Luo K, Lou Z. Nucleic Acids Res. 2020 Dec 16;48(22):12711-12726. doi: 10.1093/nar/gkaa1090. PubMed
Bromodomain protein BRD4 is an epigenetic activator of B7-H6 expression in acute myeloid leukemia. Baragano Raneros A, Rodriguez RM, Bernardo Florez A, Palomo P, Colado E, Minguela A, Suarez Alvarez B, Lopez-Larrea C. Oncoimmunology. 2021 Mar 25;10(1):1897294. doi: 10.1080/2162402X.2021.1897294. PubMed
Pim kinase inhibitor co-treatment decreases alternative non-homologous end-joining DNA repair and genomic instability induced by topoisomerase 2 inhibitors in cells with FLT3 internal tandem duplication. Scarpa M, Kapoor S, Tvedte ES, Doshi KA, Zou YS, Singh P, Lee JK, Chatterjee A, Ali MKM, Bromley RE, Hotopp JCD, Rassool FV, Baer MR. Oncotarget. 2021 Aug 31;12(18):1763-1779. doi: 10.18632/oncotarget.28042. eCollection 2021 Aug 31. PubMed
c-JUN inhibits mTORC2 and glucose uptake to promote self-renewal and obesity. Serna R, Ramrakhiani A, Hernandez JC, Chen CL, Nakagawa C, Machida T, Ray RB, Zhan X, Tahara SM, Machida K. iScience. 2022 Apr 29;25(6):104325. doi: 10.1016/j.isci.2022.104325. eCollection 2022 Jun 17. PubMed

If you have published an article using this material, please email us at to have your article added to this page.